386 related articles for article (PubMed ID: 10462375)
1. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells.
Wang Y; Ripperger J; Fey GH; Samols D; Kordula T; Wetzler M; Van Etten RA; Baumann H
Hepatology; 1999 Sep; 30(3):682-97. PubMed ID: 10462375
[TBL] [Abstract][Full Text] [Related]
2. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
3. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
4. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
5. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
Paling NR; Welham MJ
Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
[TBL] [Abstract][Full Text] [Related]
6. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
9. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
Wheadon H; Edmead C; Welham MJ
Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
[TBL] [Abstract][Full Text] [Related]
10. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
11. Albumin activates ERK via EGF receptor in human renal epithelial cells.
Reich H; Tritchler D; Herzenberg AM; Kassiri Z; Zhou X; Gao W; Scholey JW
J Am Soc Nephrol; 2005 May; 16(5):1266-78. PubMed ID: 15829704
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.
Suh HN; Lee YJ; Han HJ
J Cell Physiol; 2009 Mar; 218(3):643-52. PubMed ID: 19006119
[TBL] [Abstract][Full Text] [Related]
15. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
16. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation.
Sobota RM; Müller PJ; Heinrich PC; Schaper F
Biochem J; 2008 May; 412(1):65-72. PubMed ID: 18271757
[TBL] [Abstract][Full Text] [Related]
18. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor.
Gao Y; Tang S; Zhou S; Ware JA
J Pharmacol Exp Ther; 2001 Feb; 296(2):426-33. PubMed ID: 11160627
[TBL] [Abstract][Full Text] [Related]
19. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.
Niu G; Bowman T; Huang M; Shivers S; Reintgen D; Daud A; Chang A; Kraker A; Jove R; Yu H
Oncogene; 2002 Oct; 21(46):7001-10. PubMed ID: 12370822
[TBL] [Abstract][Full Text] [Related]
20. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
